DT
Therapeutic Areas
Mochida Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Fostamatinib (TAK-079 / MND-379) | Chronic Immune Thrombocytopenia (ITP) | Launched |
| MO-825 | Atopic Dermatitis | Phase 3 |
| MO-728 | Ulcerative Colitis | Phase 2 |
| MO-858 | Solid Tumors | Phase 1/2 |